lebrikizumab

Lilly's lebrikizumab, delayed at FDA, clears eczema in people with skin of color
Fierce Biotech
Mon, 03/11/24 - 05:11 pm
Eli Lilly
eczema
lebrikizumab
FDA
Eli Lilly Was Hoping for 5 Big Drug Launches This Year. Here's How It Has Done Thus Far.
Motley Fool
Fri, 11/10/23 - 12:19 pm
Eli Lilly
donanemab
tirzepatide
mirikizumab
lebrikizumab
pirtobrutinib
FDA Rejects Lilly’s Eczema Treatment Over Third-Party Manufacturing Issues
BioSpace
Mon, 10/2/23 - 10:36 am
Eli Lilly
lebrikizumab
atopic dermatitis
eczema
FDA
drug manufacturing
Pharma’s Biggest Losses: Once-Dropped Drugs Make Lucrative Comebacks
BioSpace
Wed, 05/10/23 - 10:18 am
Gilead Sciences
GSK
momelotinib
Roche
Eli Lilly
lebrikizumab
Merck
Zejula
Amgen
Galenica
Veltassa
Cubicin
Eli Lilly unveils new data from atopic dermatitis therapy trials
Clinical Trials Arena
Tue, 05/2/23 - 10:22 am
Eli Lilly
clinical trial
eczema
atopic dermatitis
lebrikizumab
JPM23: Amid launch spree, Eli Lilly expects revenue growth at the 'high end of the industry,' CFO says
Fierce Pharma
Thu, 01/12/23 - 10:27 am
JPMHC 2023
Eli Lilly
pertibrutinib
donanemab
mirikizumab
lebrikizumab
Eli Lilly’s 2023 guidance: Up to 4 new drugs on the way
Medical Marketing and Media
Tue, 12/13/22 - 11:54 pm
Eli Lilly
donanemab
mirikizumab
lebrikizumab
pirtobrutinib
Lilly, after making $1B bet, posts 'compelling' late-phase data on Dupixent rival
Fierce Biotech
Mon, 03/28/22 - 10:20 am
Eli Lilly
lebrikizumab
Demira
Sanofi
Regeneron
Dupixent
atopic dermatitis
Lilly's Phase 3 Study Of Lebrikizumab In Atopic Dermatitis Meets All Goals
NASDAQ
Tue, 12/21/21 - 10:30 am
Eli Lilly
lebrikizumab
monoclonal antibodies
atopic dermatitis
clinical trials
Lilly, swinging at the king, shows Dupixent rival works in phase 3, but wait for key figures goes on
Fierce Biotech
Mon, 08/16/21 - 12:25 pm
Eli Lilly
lebrikizumab
Sanofi
Regeneron
Dupixent
atopic dermatitis
clinical trials
Lilly’s lebrikizumab looks to outdo Dupixent
EP Vantage
Mon, 08/2/21 - 10:48 am
Eli Lilly
lebrikizumab
atopic dermatitis
Dupixent
Sanofi
Regeneron
Why Dermira Stock Jumped Again Today
Motley Fool
Tue, 03/19/19 - 08:19 pm
Demira
lebrikizumab
atopic dermatitis
Dermira shares double on positive eczema data
Biopharma Dive
Mon, 03/18/19 - 05:03 pm
Dermira
lebrikizumab
clinical trials
eczema
AstraZeneca sweeps out a PhIII asthma flop, a PD-1 drug and some other rejects as Q4 tally disappoints
Endpoints
Fri, 02/2/18 - 09:18 am
AstraZeneca
PD-1 inhibitors
asthma
tralokinumab
lebrikizumab
Dermira Commits $135M for Global Rights to Roche Eczema Drug
Xconomy
Tue, 08/8/17 - 11:15 pm
Demira
Roche
eczema
lebrikizumab
Top asthma drug at Roche posts 1 win, 1 flop in identical PhIIIs
Fierce Biotech
Mon, 02/29/16 - 10:30 am
Roche
Genentech
asthma
clinical trials
lebrikizumab
Roche drug cuts asthma attacks, improves lung function -study
Yahoo/Reuters
Tue, 03/4/14 - 10:15 pm
Roche
asthma
lebrikizumab
Roche CEO Schwan spotlights Roche's top three blockbuster hopefuls
Fierce Biotech
Mon, 08/22/11 - 01:16 pm
Roche
Severin Schwan
Metmab
lung cancer
lebrikizumab
Pertuzumab
asthma
breast cancer
Roche asthma drug shows promise in mid-stage trial
Reuters
Thu, 08/4/11 - 09:57 am
Roche
asthma
lebrikizumab